The combination treatment was associated with a higher continuous abstinence rate at @ weeks ( @ % vs @ % ; odds ratio -LSB- OR -RSB- , @ ; @ % CI , @-@ @ ; P = @ ) and @ weeks ( @ % vs @ % ; OR , @ ; @ % CI , @-@ @ ; P = @ ) and point prevalence abstinence rate at @ months ( @ % vs @ % ; OR , @ ; @ % CI , @-@ @ ; P = @ ) .